Search content
Sort by
Showing 3 of 3 results by Heartchain
Re: [ANN][ICO] HEARTCHAIN - Revolutionizing How Life Science Ventures Reach Success
Can you give me more information about this? Much better with pictures for a clear description. It should be more interesting, shouldn't it?
There should be several pictures in the post. Are you not able to see them? There are also links to our website and whitepaper in the post which should be able to answer all your questions.
What further information are you looking for?
[ANN][ICO] HEARTCHAIN - Revolutionizing How Life Science Ventures Reach Success
REVOLUTIONIZING THE WAY MEDICAL INNOVATIONS ARE SUPPORTED
HeartChain, by utilizing blockchains and smart contracts, makes sponsoring the development of medical innovative products accessible, transparent and friction-free for both sponsors and innovators.
WHY HEARTCHAIN?
THE HCT TOKEN
HeartChains mission is to create a new paradigm to spur innovation in medicine. We intend to fulfill this mission through the HeartChain token (HCT). Ownership of HCT grants rights to the token holder to participate on the HeartChain platform and view information and analysis usable in deciding whether to purchase the tokens of medical innovation projects.
Public Pre-ICO - June 30,2018
HeartChain Full ICO - July 31,2018
Token - ERC20
26,666,667 HCT Issued For The ICO
First 20,000,000 - 1HCT = $1
Remaining 6,666,667 - 1HCT = $1.50
HeartChain Full ICO - July 31,2018
Token - ERC20
26,666,667 HCT Issued For The ICO
First 20,000,000 - 1HCT = $1
Remaining 6,666,667 - 1HCT = $1.50
ROADMAP
TEAM
The HeartChain management team leverages its extensive network of relationships built over the years in the medical,
technology, investment, and financial sectors to mobilize resources and build the HeartChain platform to bring together
start-up innovation companies and prospective sponsors to radically change the medical innovation funding process.
technology, investment, and financial sectors to mobilize resources and build the HeartChain platform to bring together
start-up innovation companies and prospective sponsors to radically change the medical innovation funding process.